Unichem Laboratories Ltd. Share Price & Stock Analysis

Unichem Laboratories Ltd. (BSE: 506690) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹3,501 Cr, it ranks #990 by market cap among the 6,197 Indian listed companies on FinBizNet, and #32 of 86 in Medicinal Chemicals and Botanical Products. At ₹500.20 (as of 16 Nov 2026), the share price is 27.2% below its 52-week high of ₹687.20 and 79.8% above its 52-week low of ₹278.20. The share price is up 8.4% over one year and down 8.0% over three months.

Key Metrics

Current Price₹500.20
Market Cap₹3,501 Cr
BSE Code506690
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio13.8
Return on Equity9.78%
Return on Assets1.09%
52-Week Range₹278.20 – ₹687.20
1-Year Price Change+8.4%
3-Month Price Change-8.0%
Beta (1Y)0.25
Dividend Yield0.00%
HeadquartersMumbai, Maharashtra
Websitewww.unichemlabs.com

Latest Quarterly Results — Q2 FY27

Revenue₹640 Cr
Net Profit₹22 Cr
Net Margin3.5%
EPS (Basic)₹3.16
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Unichem Laboratories Ltd. Quarterly Revenue and Profit Trend

Unichem Laboratories Ltd. reported revenue of ₹640 Cr in Q2 FY27, up 10.6% from ₹579 Cr in Q2 FY26 and up 1.2% from ₹633 Cr in Q1 FY27. It posted a net profit of ₹22 Cr for the quarter, against a net loss of ₹12 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹521 Cr (Q3 FY26) to ₹640 Cr (Q2 FY27). The company reported a net loss in 2 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹640 Cr₹22 Cr3.5%
Q1 FY27₹633 Cr₹41 Cr6.6%
Q4 FY26₹575 Cr₹11 Cr1.9%
Q3 FY26₹521 Cr₹264 Cr50.7%
Q2 FY26₹579 Cr−₹12 Cr−2.1%
Q1 FY26₹527 Cr−₹10 Cr−2.0%
Q4 FY25₹587 Cr₹53 Cr9.0%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 70.22% of Unichem Laboratories Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 37.3% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Unichem Laboratories Ltd.

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.

Products and Services

1. Pharmaceuticals-This segment manufactures and sells pharmaceutical products.

Business Segments

1. Pharmaceuticals-100%

Unichem Laboratories Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Unichem Laboratories Ltd.₹3,501 Cr13.89.78%₹640 Cr+8.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Unichem Laboratories Ltd.?

Unichem Laboratories Ltd. is trading at ₹500.20, with a market capitalisation of ₹3,501 Cr.

Which sector does Unichem Laboratories Ltd. belong to?

Unichem Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Unichem Laboratories Ltd.?

Unichem Laboratories Ltd. has a P/E of 13.8 and a return on equity of 9.78%.

What is the stock symbol of Unichem Laboratories Ltd.?

Unichem Laboratories Ltd. is listed on the BSE under the scrip code 506690.

How has Unichem Laboratories Ltd.'s share price moved over the past year?

Unichem Laboratories Ltd.'s share price is up 8.4% over one year and down 8.0% over three months. Its 52-week range is ₹278.20 to ₹687.20.

What were Unichem Laboratories Ltd.'s latest quarterly results?

In Q2 FY27, Unichem Laboratories Ltd. reported revenue of ₹640 Cr and net profit of ₹22 Cr, with basic EPS of ₹3.16 (consolidated, parsed from the company's exchange filing).

How have Unichem Laboratories Ltd.'s revenue and profit changed over the past year?

Unichem Laboratories Ltd. reported revenue of ₹640 Cr in Q2 FY27, up 10.6% from ₹579 Cr in Q2 FY26 and up 1.2% from ₹633 Cr in Q1 FY27.

What is the promoter holding in Unichem Laboratories Ltd.?

Promoters held 70.22% of Unichem Laboratories Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.